Company / Operating Margin
Century Therapeutics, Inc. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-2096.5%
FY2025
5-year range
-6556.9% / -1825.0%
FY2022-FY2025
Trend
+68.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 2 years of decline, reaching -2096.5%.
Based on SEC 10-K filings.
-2096.5% in FY2025 with a 3-year CAGR of -271.5%.
Improved from -2574.2% to -2096.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -271.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 68.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2096.5% | +68.0% |
| FY2024 | -6556.9% | -154.7% |
| FY2023 | -2574.2% | -41.0% |
| FY2022 | -1825.0% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026